Farrow Financial Inc. lowered its position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 2.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 21,110 shares of the technology company’s stock after selling 582 shares during the period. Plexus comprises about 2.1% of Farrow Financial Inc.’s portfolio, making the stock its 13th biggest position. Farrow Financial Inc. owned about 0.08% of Plexus worth $3,308,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. lifted its stake in shares of Plexus by 12.1% in the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company’s stock valued at $121,000 after purchasing an additional 84 shares during the period. Glenmede Trust Co. NA lifted its stake in shares of Plexus by 4.4% in the 3rd quarter. Glenmede Trust Co. NA now owns 2,453 shares of the technology company’s stock valued at $335,000 after purchasing an additional 104 shares during the period. GAMMA Investing LLC lifted its stake in shares of Plexus by 17.2% in the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company’s stock valued at $139,000 after purchasing an additional 131 shares during the period. Quarry LP lifted its stake in shares of Plexus by 573.5% in the 3rd quarter. Quarry LP now owns 229 shares of the technology company’s stock valued at $31,000 after purchasing an additional 195 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in shares of Plexus by 89.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after purchasing an additional 219 shares during the period. Institutional investors own 94.45% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the company. Stifel Nicolaus assumed coverage on Plexus in a research note on Tuesday, February 4th. They set a “hold” rating and a $152.00 price target on the stock. Needham & Company LLC upped their price target on Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Benchmark reaffirmed a “buy” rating and set a $165.00 price target on shares of Plexus in a research note on Wednesday, January 22nd. Finally, StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Plexus presently has a consensus rating of “Moderate Buy” and an average price target of $163.00.
Plexus Stock Performance
Shares of PLXS opened at $124.76 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The stock has a 50 day moving average price of $146.94 and a two-hundred day moving average price of $145.69. The firm has a market capitalization of $3.37 billion, a P/E ratio of 28.95 and a beta of 0.90. Plexus Corp. has a 52 week low of $90.18 and a 52 week high of $172.89.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Equities analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CEO Todd P. Kelsey sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now directly owns 74,271 shares of the company’s stock, valued at $11,615,241.69. This represents a 1.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Randy J. Martinez sold 887 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total value of $124,641.24. Following the completion of the transaction, the director now directly owns 4,831 shares of the company’s stock, valued at approximately $678,852.12. This represents a 15.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 19,458 shares of company stock valued at $2,786,515. Corporate insiders own 1.76% of the company’s stock.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- How Technical Indicators Can Help You Find Oversold Stocks
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Which Wall Street Analysts are the Most Accurate?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- There Are Different Types of Stock To Invest In
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.